099190

i-SENS is a global in vitro diagnostics company that researches, develops, and manufactures medical sensors and measuring instruments based on electrochemical and biosensor technologies. The company operates two main business segments: blood glucose monitoring and point-of-care testing (POCT). Its blood glucose monitoring portfolio includes self-monitoring blood glucose systems (BGMS) consisting of meters, test strips, and lancets, as well as continuous glucose monitoring (CGM) systems, notably the CareSens Air, which was launched in 2023. The POCT segment offers diagnostic analyzers for blood gas, electrolytes, coagulation, and immunoassay, serving hospitals, clinics, and home-care settings. i-SENS serves customers in Korea, the United States, and Europe, through its own brand, CareSens, and via OEM and ODM partnerships with major global healthcare companies. The company was founded in 2000 by researchers from Kwangwoon University and listed on the KOSDAQ market in 2013. It maintains production facilities in Korea and China and holds subsidiaries in various regions to support its global distribution and manufacturing operations.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Medical Devices Homepage i-sens.com
Sector Healthcare IR page i-sens.com
Tags
blood glucose monitoring, continuous glucose monitoring, point-of-care testing, biosensors, electrochemical sensors, blood gas analysis, electrolyte analysis, coagulation testing, immunoassay, diagnostic instruments, medical devices, in vitro diagnostics, CareSens, CareSens Air, CareSens I, CareSens II, CareSens Dual, CareSens POP, CareSens PRO, CareSens N, CareSens N BLE, CareSens N NFC, CareSens N IoT, CareSens Expert Plus, CareSens N Premier, CareSens N Mini, i-Smart 30, i-Smart 300, i-Smart 30 VET, i-SmartCare 10, A1Care Analyzer, ivisen IA-1100, CoaguSense, AgaMatrix, Precision Biosensors, Nano-Ditech, i-SENS GmbH, i-SENS USA, i-SENS China, i-SENS Europe, i-SENS Chile, i-SENS India, i-SENS Mexico, i-SENS Peru, i-SENS Hong Kong, i-SENS Malaysia, i-SENS Biz, i-SENS (Jiangsu), i-SENS BIOSENSORS INDIA, i-SENS Chile SpA, i-SENS Hong Kong Limited, i-SENS Europe Office, i-SENS China Office, i-SENS USA Inc., i-SENS Biosensors Malaysia Sdn. Bhd., i-SENS (Jiangsu) Co. Ltd., i-SENS Biz Inc., i-SENS MEXICO S.A. DE C.V., i-SENS Chile SpA., i-SENS BIOSENSORS INDIA Pvt. Ltd., i-SENS Peru Office
Press page —

Metrics

Valuation  
Market cap ₩ 454.941B
Market cap (USD) $ 334.828M
P/E -118.10
PEG —
P/BV 1.34
P/S 1.39
P/OCF 17.57
P/FCF -62.13
Dividend yield —
Turnover / mcap —
Returns  
ROE -1.6%
ROI -1.6%
ROIC 1.9%
Profit margin -1.6%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) —
Quality score -17.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 315.445B 291.138B 265.12B 264.837B 232.935B 203.708B 189.844B 172.997B 156.964B 132.468B 101.921B 95.608B 82.863B
Net profit -5.149B -1.794B 3.709B 16.138B 25.451B 26.839B 23.426B 22.619B 15.73B 17.561B 14.716B 14.466B 18.642B
Free cash flow -7.597B 7.783B -29.04B -15.333B -30.406B 26.976B 31.025B 10.728B -1.285B — — — —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 15.917K 16.1K — — — — — — — — — — —
Price performance 12m -0.01 — — — — — — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (KRW) 32.9B 36.6B 48.8B 45.2B 39.3B 49.6B 52B 58.3B 65.5B 67.3B
↳ YoY growth +39.9% +11.2% +33.4% -7.5% -13.0% +26.1% +5.0% +12.0% +12.5% +2.8%
↳ 5y CAGR +10.8% +8.5% +7.3% +3.6% +7.7% +11.4%
Other receivables (KRW) — — — — — — — 5.69B 5.54B 7.52B
Borrowings, current (KRW) — 4.15B 4.2B 15B 4.42B 4.5B 33.4B 93.1B 57.6B 40.8B
Borrowings, non-current (KRW) 23B — 34.4B 19.9B 42.8B 94.2B 63.7B 45.7B 112B 61.5B
Bonds payable (KRW) — — — — — — 0.00 0.00 38.4B 40.8B
Lease liabilities (KRW) — — 0.00 1.57B 2.93B 2.14B 3.74B 4.97B 4.57B 3B
Cash and deposits (KRW) 25.5B 27.5B 27B 34.5B 30.5B 47.2B 61.6B 45.3B 67.6B 45B
Intangible assets (KRW) 23.8B 19.3B 20.1B 16B 14.1B 14.1B 15B 38.5B 32.5B 32.8B
Right-of-use assets (KRW) — — 0.00 2.51B 3.85B 3.08B 4.83B 6.04B 5.57B 3.6B
Net debt (borrowings + leases - cash) (KRW) -2.5B -23.3B -22.8B -17.9B 19.6B 53.7B 39.3B 98.5B 106B 60.3B
Cash flow detail
Operating cash flow (KRW) 11.7B 22.4B 19.5B 38B 34.6B 17.2B 6.65B 13B 23B 20.1B
Purchases of property, plant and equipment (KRW) -7.65B -23.7B -8.82B -6.93B -7.64B -47.6B -22B -42.1B -15.2B -27.7B
Purchases of intangible assets (KRW) -943M -550M -1.72B -694M -365M -564M -1.28B -564M -404M -741M
Dividends paid (cash effect) (KRW) — -1.37B -1.37B -2.04B -2.72B -3.4B -4.08B -4.81B -2.75B -2.76B
Share buybacks (cash effect) (KRW) — — -2.97B — — — — 0.00 0.00 -2B
Interest paid (cash effect) (KRW) -513M -1.37B -365M -1.66B -1.1B -808M -1.18B -2.8B -5.02B -4.82B
Income taxes paid (cash effect) (KRW) -6.14B -6.36B -2.67B -5.65B -8.12B -6.19B -6.61B -7.57B 1.82B -4.69B
Free cash flow (OCF - PPE - intangibles) (KRW) 3.13B -1.83B 9.01B 30.3B 26.6B -31B -16.6B -29.6B 7.38B -8.34B
Income detail
Total comprehensive income (KRW) 17.1B 13.5B 22.4B 24B 23.8B 52.2B 18.8B 2B 34B -7.13B
Comprehensive income to owners (KRW) 17.2B 14.3B 22.5B 24.3B 23.5B 52.1B 18.8B 2.22B 34B -5.78B
Reported Mar 30, 2018 Mar 30, 2020 Mar 18, 2021 May 15, 2020 Mar 18, 2021 Mar 20, 2024 Mar 18, 2025 Mar 18, 2026 Mar 18, 2026 Mar 18, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

주요사항보고서(자기주식취득결정) Bull 2 Bear 0 Capital return

Prompts

i-SENS (ticker 099190), listed in South Korea.

ETFs Holding i-SENS

ETF Weight in ETF Shares Market value As of
AVEE 0.02% 2,380 $ 21.739K Nov 16, 2026
DEXC 0.01% 1,466 $ 14.677K Nov 12, 2026
DFEV 0.00% 10,788 $ 108.006K Nov 12, 2026
DFSE 0.00% 1,827 $ 18.291K Nov 12, 2026
DFAE 0.00% 21,130 $ 211.546K Nov 12, 2026
DFEM 0.00% 17,161 $ 171.81K Nov 12, 2026
DFAX 0.00% 14,994 $ 150.115K Nov 12, 2026
AVEM 0.00% 7,170 $ 65.49K Nov 16, 2026
AVXC 0.00% 6 $ 54.80 Nov 16, 2026